<DOC>
	<DOC>NCT02423187</DOC>
	<brief_summary>To investigate the safety and efficacy of long-term combination therapy with rabeprazole and low-dose aspirin.</brief_summary>
	<brief_title>Rabeprazole Specific Clinical Experience Investigation for the Long-term Combination Therapy With Low-dose Aspirin</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Duodenal Ulcer</mesh_term>
	<mesh_term>Stomach Ulcer</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Rabeprazole</mesh_term>
	<criteria>Inclusion criteria: 1. Patients taking longterm lowdose aspirin for prevention of thrombus/embolism at the start of administration of rabeprazole (including patients who start lowdose aspirin on the same day as the start of administration of rabeprazole). 2. Patients with a history of gastric/duodenal ulcers. 3. Patients requiring longterm use of rabeprazole for prevention of recurrence of gastric/duodenal ulcers induced by lowdose aspirin. Exclusion criteria: 1. Patients with gastric/duodenal ulcers at the start of administration of rabeprazole. 2. Patients with active upper gastrointestinal bleeding at the start of administration of rabeprazole. 3. Patients with contraindication for rabeprazole.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Stomach ulcer</keyword>
	<keyword>Duodenal ulcer</keyword>
	<keyword>Rabeprazole</keyword>
	<keyword>Recurrence</keyword>
</DOC>